
Antoinette R. Tan
Advertisement
Articles by Antoinette R. Tan


24 ARV-471, a PROTAC Estrogen Receptor (ER) Degrader in Advanced ER+/Human Epidermal Growth Factor Receptor 2 (HER2)– Breast Cancer: Phase 2 Expansion (VERITAC) of a Phase 1/2 Study
BySara A. Hurvitz, MD,Anne F. Schott, MD,Cynthia X. Ma, MD, PhD,Erika P. Hamilton, MD,Rita Nanda, MD,George Zahrah,Natasha Hunter, MD,Antoinette R. Tan,Melinda L. Telli, MD,Jesus Anampa Mesias,Rinath Jeselsohn,Pamela N. Munster, MD,Haolan Lu,Richard Gedrich,Cecile Mather,Janaki Parameswaran,Hyo S Han
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Combatting Toxicities and Leveraging Novel Therapies in Lung Cancer Care
2
Elucidating Treatment Selection for Metastatic HSPC at ASCO GU 2026
3
Acalabrutinib Approval Offers Time-Limited Approach in CLL/SLL
4
Navigating Oligometastasis and Oligoprogression in Stage IV Breast Cancer
5

